A Phase 3 Study of Eltrombopag vs Standard First-Line Management for Newly-Diagnosed Immune Thrombocytopenia (ITP) in Children

Grant

Awarded By

Total Award Amount

  • 53675.00

    • Direct Costs

  • 39467.00

    • Sponsor Award Id

    • Contributor

  • Jeffrey Lebensburger   Principal Investigator